Hydroxycarbamide

Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and essential thrombocythemia. In sickle-cell disease it increases fetal hemoglobin and decreases the number of attacks. It is taken by mouth.

 More from Wikipedia

Metrics Summary

Total Publications

Lifetime

4,607

Prior Five Years

726

Total Citations

Lifetime

77,142

Prior Five Years

4,077

Total Scholars

Lifetime

9,797

Prior Five Years

6,912

Institutional Rankings

Global (Worldwide)

Academic Institutions Lifetime		Academic Institutions Prior Five Years		Non-academic Institutions Lifetime
#1	University of Chicago United States	#1	Northwestern University United States	#1	Cincinnati Children's Hospital Medical Center United States
#2	Harvard University United States	#2	University of Miami United States	#2	National Heart, Lung, and Blood Institute, National Institutes of Health United States
#3	Johns Hopkins University United States	#3	University of Florence Italy	#3	Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Italy
#4	McGill University Canada			#4	St. Jude Children's Research Hospital United States
#5	Wake Forest University United States			#5	UCSF Benioff Children’s Hospital Oakland United States
#6	Thomas Jefferson University United States			#7	Northwell Health United States
#7	Boston University United States			#8	Mayo Clinic United States
#8	Georgetown University United States			#9	Hospital for Sick Children Canada
#9	University of Maryland School of Medicine United States			#10	Institut National de la Santé et de la Recherche Médicale France
#10	Howard University United States				Show More
	Show More

National Institutional Rankings

Publications and Citation History

Publications based on Disciplines

Scholars based on Disciplines

Publications based on Fields

Scholars based on Fields

Highly Ranked Scholars™

Lifetime

Prior Five Years

Evaluation Period:

Highly Cited Publications

Lifetime